The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC)

Clinical trial NCT03472716 · UNKNOWN

Trial details

NCT number: NCT03472716
Sponsor: Centre Leon Berard
Status: UNKNOWN
Study type: OBSERVATIONAL

Pancreas Adenocarcinoma

Start date: 2018-05-22
Primary completion: 2023-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.